NDC 43772-0002

Neurosode

Glandula Suprarenalis Suis, Brain (suis), Kidney (suis), Ubiquinone, Agaricus Muscarius, Coccus Cacti, Conium Maculatum, Phosphorus, Rhus Tox, Naja Tripudians, Latrodectus Mactans, Tarentula Cubensis, Gelsemium Sempervirens, Epstein Barr Nosodes, Herpes Zoster Nosodes, Morbillinum, Poliomyelitis Nosodes, Hepatitis B Nosodes, Coxsackie B1 Nosodes, Coxsackie B4 Nosodes, Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methyl Paraben, Propyl Paraben, Sodium Benzoate,

Neurosode is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Synergy Formulas, Inc. The primary component is Sus Scrofa Adrenal Gland; Pork Brain; Pork Kidney; Ubidecarenone; Amanita Muscaria Var. Muscaria Fruiting Body; Protortonia Cacti; Conium Maculatum Flowering Top; Phosphorus; Toxicodendron Pubescens Leaf; Naja Naja Venom; Aspartame; Benzalkonium Chloride; Formaldehyde; Methylene Chloride; Methylparaben; Propylparaben; Sodium Benzoate; Sodium Citrate; Titanium Dioxide; Zinc Oxide; Latrodectus Mactans; Citharacanthus Spinicrus; Gelsemium Sempervirens Root; Salicylic Acid; Corticotropin; Cortisone Acetate; Eugenol; Stearyl Alcohol; Xylitol; Estrone; Benzoic Acid; Chlorine; Potassium Sorbate; Sorbitol; Resorcinol; Benzyl Alcohol; Lactic Acid, Dl-; Isopropyl Palmitate; Boric Acid; Acetic Acid; Phenylbutazone; Petrolatum; Lead; Human Herpesvirus 4; Human Herpesvirus 3; Measles Virus; Poliovirus; Hepatitis B Virus; Human Coxsackievirus B1; Human Coxsackievirus B4.

Product ID43772-0002_ea5c04d0-23a1-4dbc-bfc8-05b96ab76e34
NDC43772-0002
Product TypeHuman Otc Drug
Proprietary NameNeurosode
Generic NameGlandula Suprarenalis Suis, Brain (suis), Kidney (suis), Ubiquinone, Agaricus Muscarius, Coccus Cacti, Conium Maculatum, Phosphorus, Rhus Tox, Naja Tripudians, Latrodectus Mactans, Tarentula Cubensis, Gelsemium Sempervirens, Epstein Barr Nosodes, Herpes Zoster Nosodes, Morbillinum, Poliomyelitis Nosodes, Hepatitis B Nosodes, Coxsackie B1 Nosodes, Coxsackie B4 Nosodes, Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methyl Paraben, Propyl Paraben, Sodium Benzoate,
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2012-08-22
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameSynergy Formulas, Inc
Substance NameSUS SCROFA ADRENAL GLAND; PORK BRAIN; PORK KIDNEY; UBIDECARENONE; AMANITA MUSCARIA VAR. MUSCARIA FRUITING BODY; PROTORTONIA CACTI; CONIUM MACULATUM FLOWERING TOP; PHOSPHORUS; TOXICODENDRON PUBESCENS LEAF; NAJA NAJA VENOM; ASPARTAME; BENZALKONIUM CHLORIDE; FORMALDEHYDE; METHYLENE CHLORIDE; METHYLPARABEN; PROPYLPARABEN; SODIUM BENZOATE; SODIUM CITRATE; TITANIUM DIOXIDE; ZINC OXIDE; LATRODECTUS MACTANS; CITHARACANTHUS SPINICRUS; GELSEMIUM SEMPERVIRENS ROOT; SALICYLIC ACID; CORTICOTROPIN; CORTISONE ACETATE; EUGENOL; STEARYL ALCOHOL; XYLITOL; ESTRONE; BENZOIC ACID; CHLORINE; POTASSIUM SORBATE; SORBITOL; RESORCINOL; BENZYL ALCOHOL; LACTIC ACID, DL-; ISOPROPYL PALMITATE; BORIC ACID; ACETIC ACID; PHENYLBUTAZONE; PETROLATUM; LEAD; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 3; MEASLES VIRUS; POLIOVIRUS; HEPATITIS B VIRUS; HUMAN COXSACKIEVIRUS B1; HUMAN COXSACKIEVIRUS B4
Active Ingredient Strength8 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 43772-0002-1

60 mL in 1 BOTTLE, DROPPER (43772-0002-1)
Marketing Start Date2012-08-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43772-0002-1 [43772000201]

Neurosode LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2012-08-22
Inactivation Date2020-01-31

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.